SMP0120859
View Pathway
|
21-Hydroxylase Deficiency (CYP21)
Rattus norvegicus
Congenital adrenal hyperplasia (CAH) refers to any of several autosomal recessive diseases resulting from mutations of genes for enzymes mediating the steps of biosynthesis of cortisol from cholesterol in the adrenal glands, also known as steroidogenesis. 21-hydroxylase deficiency, also known as CYP21 deficiency or CAH1, is an autosomal recessive disorder that accounts for the vast majority of cases of CAH. This deficiency affects cells in the adrenal cortex of the adrenal glands, and due to the deficiency in an enzyme used in many pathways. This prevents the completion of several hormone biosynthesis pathways, including those producing aldosterone and cortisol, and leads to a buildup of their precursors, including 17a-hydroxypregnenolone, which are then processed by the pathways that produce androgen hormones including testosterone.
This disorder can vary in severity, depending on the amount of functional enzyme present. The most severe form is known as the salt-wasting form of 21-hydroxylase, and is caused by a complete lack of functional enzyme. This form is called the salt-wasting form, as the lack of aldosterone produced leads to high levels of sodium excreted in the urine, causing infant blood volume to decrease. High potassium levels in blood are also often observed, but if properly diagnosed, saline solution and hydrocortisone can restore normal blood levels and sodium content. In addition, males are typically visually unaffected, but females often possess ambiguous genitalia due to the excess exposure to testosterone during development. The second most severe form is known as the simple virilising form, which does not involve the salt loss of the salt-wasting form, due to a partially functional 21-hydroxylase enzyme. However, the androgen hormones build up similarly, leading to females with some amount of virilisation, or some amount of male characteristics, including ambiguous genitalia. The third and least severe form, known as the non-classical or late onset form, has the highest function in 21-hydroxylase enzymes, and leads to the smallest buildup of androgen hormones. This means that females exhibit little to no virilisation at birth, but as they age can experience male-associated hair growth and baldness, as well as decreased fertility and menstruation irregularities. It can also lead to an early puberty in both males and females, though treatment can help prevent this if it is caught in time.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0000576
View Pathway
|
21-Hydroxylase Deficiency (CYP21)
Homo sapiens
Congenital adrenal hyperplasia (CAH) refers to any of several autosomal recessive diseases resulting from mutations of genes for enzymes mediating the steps of biosynthesis of cortisol from cholesterol in the adrenal glands, also known as steroidogenesis. 21-hydroxylase deficiency, also known as CYP21 deficiency or CAH1, is an autosomal recessive disorder that accounts for the vast majority of cases of CAH. This deficiency affects cells in the adrenal cortex of the adrenal glands, and due to the deficiency in an enzyme used in many pathways. This prevents the completion of several hormone biosynthesis pathways, including those producing aldosterone and cortisol, and leads to a buildup of their precursors, including 17a-hydroxypregnenolone, which are then processed by the pathways that produce androgen hormones including testosterone.
This disorder can vary in severity, depending on the amount of functional enzyme present. The most severe form is known as the salt-wasting form of 21-hydroxylase, and is caused by a complete lack of functional enzyme. This form is called the salt-wasting form, as the lack of aldosterone produced leads to high levels of sodium excreted in the urine, causing infant blood volume to decrease. High potassium levels in blood are also often observed, but if properly diagnosed, saline solution and hydrocortisone can restore normal blood levels and sodium content. In addition, males are typically visually unaffected, but females often possess ambiguous genitalia due to the excess exposure to testosterone during development. The second most severe form is known as the simple virilising form, which does not involve the salt loss of the salt-wasting form, due to a partially functional 21-hydroxylase enzyme. However, the androgen hormones build up similarly, leading to females with some amount of virilisation, or some amount of male characteristics, including ambiguous genitalia. The third and least severe form, known as the non-classical or late onset form, has the highest function in 21-hydroxylase enzymes, and leads to the smallest buildup of androgen hormones. This means that females exhibit little to no virilisation at birth, but as they age can experience male-associated hair growth and baldness, as well as decreased fertility and menstruation irregularities. It can also lead to an early puberty in both males and females, though treatment can help prevent this if it is caught in time.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0120871
View Pathway
|
27-Hydroxylase Deficiency
Rattus norvegicus
Sterol 27-hydroxylase is a mitochondrial cytochrome P-450 species (CYP27) that catalyzes the first step in the degradation of steroid side chain in cholesterol to produce bile acids in the liver. When there are low concentrations of 27-Hydroxylase, patients will exhibit cerebrotendinous xanthomatosis, an autosomal recessive disorder characterized by the accumulation of cholestanol and cholesterol due to the inability to break down the lipids. The formation of xanthomas (deposits of lipids) in the nervous system and tendons will cause symptoms such as dementia, ataxia, and cataracts. Other symptoms may include damaged liver cells and body tissues.
|
|
- (24R)-Cholest-5-ene-3-β,7-α,24...
- 24-Hydroxycholesterol
- 25-Hydroxycholesterol
- 27-Deoxy-5b-cyprinol
- 27-Hydroxycholesterol
- 3 α,7 α,24-Trihydroxy-5β-chole...
- 3 α,7 α,26-Trihydroxy-5β-chole...
- 3 β-Hydroxy-5-cholestenoate
- 3'-AMP
- 3a,7a,12a,24-Tetrahydroxy-5b-c...
- 3a,7a,12a-Trihydroxy-5b-24-oxo...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a-Dihydroxy-5b-cholest-24-...
- 3a,7a-Dihydroxy-5b-cholestan-2...
- 3a,7a-Dihydroxy-5b-cholestane
- 3a,7a-Dihydroxy-5b-cholestanoy...
- 3α,7α,12α-Trihydroxy-5β-choles...
- 3α,7α-Dihydroxycoprostanic aci...
- 3β,7α-Dihydroxy-5-cholestenoat...
- 5-b-Cholestane-3a ,7a ,12a-tri...
- 5b-Cyprinol sulfate
- 7 α,26-Dihydroxy-4-cholesten-3...
- 7-a,25-Dihydroxycholesterol
- 7-a,27-Dihydroxycholesterol
- 7a,12a-Dihydroxy-5b-cholestan-...
- 7a,12a-Dihydroxy-cholestene-3-...
- 7a-Hydroxy-5b-cholestan-3-one
- 7a-Hydroxy-cholestene-3-one
- 7a-Hydroxycholesterol
- 7α-Hydroxy-3-oxo-4-cholestenoa...
- Adenosine diphosphate
- Adenosine triphosphate
- CE(22:2(13Z,16Z))
- Chenodeoxycholic acid
- Chenodeoxycholic acid glycine ...
- Chenodeoxycholoyl-CoA
- Cholesterol
- Cholic acid
- Choloyl-CoA
- Coenzyme A
- Deoxycholic acid
- Deoxycholic acid glycine conju...
- FAD
- Glycine
- Glycocholic acid
- Heme
- Iron
- Lithocholic acid
- Lithocholic acid glycine conju...
- Lithocholyltaurine
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Palmitic acid
- Propionyl-CoA
- Pyrophosphate
- Taurine
- Taurochenodesoxycholic acid
- Taurocholic acid
- Taurodeoxycholic acid
- Water
- (
show all
show less
)
|
|
SMP0000720
View Pathway
|
27-Hydroxylase Deficiency
Homo sapiens
Sterol 27-hydroxylase is a mitochondrial cytochrome P-450 species (CYP27) that catalyzes the first step in the degradation of steroid side chain in cholesterol to produce bile acids in the liver. When there are low concentrations of 27-Hydroxylase, patients will exhibit cerebrotendinous xanthomatosis, an autosomal recessive disorder characterized by the accumulation of cholestanol and cholesterol due to the inability to break down the lipids. The formation of xanthomas (deposits of lipids) in the nervous system and tendons will cause symptoms such as dementia, ataxia, and cataracts. Other symptoms may include damaged liver cells and body tissues.
|
|
- (24R)-Cholest-5-ene-3-β,7-α,24...
- 24-Hydroxycholesterol
- 25-Hydroxycholesterol
- 27-Deoxy-5b-cyprinol
- 27-Hydroxycholesterol
- 3 α,7 α,24-Trihydroxy-5β-chole...
- 3 α,7 α,26-Trihydroxy-5β-chole...
- 3 β-Hydroxy-5-cholestenoate
- 3'-AMP
- 3a,7a,12a,24-Tetrahydroxy-5b-c...
- 3a,7a,12a-Trihydroxy-5b-24-oxo...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a-Dihydroxy-5b-cholest-24-...
- 3a,7a-Dihydroxy-5b-cholestan-2...
- 3a,7a-Dihydroxy-5b-cholestane
- 3a,7a-Dihydroxy-5b-cholestanoy...
- 3α,7α,12α-Trihydroxy-5β-choles...
- 3α,7α-Dihydroxycoprostanic aci...
- 3β,7α-Dihydroxy-5-cholestenoat...
- 5-b-Cholestane-3a ,7a ,12a-tri...
- 5b-Cyprinol sulfate
- 7 α,26-Dihydroxy-4-cholesten-3...
- 7-a,25-Dihydroxycholesterol
- 7-a,27-Dihydroxycholesterol
- 7a,12a-Dihydroxy-5b-cholestan-...
- 7a,12a-Dihydroxy-cholestene-3-...
- 7a-Hydroxy-5b-cholestan-3-one
- 7a-Hydroxy-cholestene-3-one
- 7a-Hydroxycholesterol
- 7α-Hydroxy-3-oxo-4-cholestenoa...
- Adenosine diphosphate
- Adenosine triphosphate
- CE(22:2(13Z,16Z))
- Chenodeoxycholic acid
- Chenodeoxycholic acid glycine ...
- Chenodeoxycholoyl-CoA
- Cholesterol
- Cholic acid
- Choloyl-CoA
- Coenzyme A
- Deoxycholic acid
- Deoxycholic acid glycine conju...
- FAD
- Glycine
- Glycocholic acid
- Heme
- Iron
- Lithocholic acid
- Lithocholic acid glycine conju...
- Lithocholyltaurine
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Palmitic acid
- Propionyl-CoA
- Pyrophosphate
- Taurine
- Taurochenodesoxycholic acid
- Taurocholic acid
- Taurodeoxycholic acid
- Water
- (
show all
show less
)
|
|
SMP0120652
View Pathway
|
27-Hydroxylase Deficiency
Mus musculus
Sterol 27-hydroxylase is a mitochondrial cytochrome P-450 species (CYP27) that catalyzes the first step in the degradation of steroid side chain in cholesterol to produce bile acids in the liver. When there are low concentrations of 27-Hydroxylase, patients will exhibit cerebrotendinous xanthomatosis, an autosomal recessive disorder characterized by the accumulation of cholestanol and cholesterol due to the inability to break down the lipids. The formation of xanthomas (deposits of lipids) in the nervous system and tendons will cause symptoms such as dementia, ataxia, and cataracts. Other symptoms may include damaged liver cells and body tissues.
|
|
- (24R)-Cholest-5-ene-3-β,7-α,24...
- 24-Hydroxycholesterol
- 25-Hydroxycholesterol
- 27-Deoxy-5b-cyprinol
- 27-Hydroxycholesterol
- 3 α,7 α,24-Trihydroxy-5β-chole...
- 3 α,7 α,26-Trihydroxy-5β-chole...
- 3 β-Hydroxy-5-cholestenoate
- 3'-AMP
- 3a,7a,12a,24-Tetrahydroxy-5b-c...
- 3a,7a,12a-Trihydroxy-5b-24-oxo...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a,12a-Trihydroxy-5b-choles...
- 3a,7a-Dihydroxy-5b-cholest-24-...
- 3a,7a-Dihydroxy-5b-cholestan-2...
- 3a,7a-Dihydroxy-5b-cholestane
- 3a,7a-Dihydroxy-5b-cholestanoy...
- 3α,7α,12α-Trihydroxy-5β-choles...
- 3α,7α-Dihydroxycoprostanic aci...
- 3β,7α-Dihydroxy-5-cholestenoat...
- 5-b-Cholestane-3a ,7a ,12a-tri...
- 5b-Cyprinol sulfate
- 7 α,26-Dihydroxy-4-cholesten-3...
- 7-a,25-Dihydroxycholesterol
- 7-a,27-Dihydroxycholesterol
- 7a,12a-Dihydroxy-5b-cholestan-...
- 7a,12a-Dihydroxy-cholestene-3-...
- 7a-Hydroxy-5b-cholestan-3-one
- 7a-Hydroxy-cholestene-3-one
- 7a-Hydroxycholesterol
- 7α-Hydroxy-3-oxo-4-cholestenoa...
- Adenosine diphosphate
- Adenosine triphosphate
- CE(22:2(13Z,16Z))
- Chenodeoxycholic acid
- Chenodeoxycholic acid glycine ...
- Chenodeoxycholoyl-CoA
- Cholesterol
- Cholic acid
- Choloyl-CoA
- Coenzyme A
- Deoxycholic acid
- Deoxycholic acid glycine conju...
- FAD
- Glycine
- Glycocholic acid
- Heme
- Iron
- Lithocholic acid
- Lithocholic acid glycine conju...
- Lithocholyltaurine
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Palmitic acid
- Propionyl-CoA
- Pyrophosphate
- Taurine
- Taurochenodesoxycholic acid
- Taurocholic acid
- Taurodeoxycholic acid
- Water
- (
show all
show less
)
|
|
SMP0120869
View Pathway
|
3-beta-Hydroxysteroid Dehydrogenase Deficiency
Rattus norvegicus
3-beta-hydroxysteroid dehydrogenase (HSD) deficiency is an extremely rare inborn error of metabolism (IEM) and autosomal recessive disorder of the steroidogenesis pathway. It is caused by an defect in the HSD3B2 gene which encodes for the 3 beta-hydroxysteroid dehydrogenase enzyme, which is responsible for forming cortisol from 11b,17a,21-trihydroxypregnenolone. When the enzyme is not correctly produced, cortisol levels in the cell are lowered, and as cortisol is used in the production of other steroids, it may affect their levels as well. 3-beta-HSD deficiency is characterized by low levels of cortisol produced in the adrenal glands. Symptoms include abnormal genitalia for both males and females, as well as infertility. There is also a more severe salt-wasting form of this deficiency, characterized by dehydration. Treatment for 3-beta-HSD deficiency includes steroid replacement, as well as sex hormone replacement during puberty to allow proper development. Surgery can also be used to correct any genital abnormalities that may occur. It is estimated that 3-beta-HSD deficiency affects less than 1 in 1,000,000 individuals, with around 60 cases reported.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0120650
View Pathway
|
3-beta-Hydroxysteroid Dehydrogenase Deficiency
Mus musculus
3-beta-hydroxysteroid dehydrogenase (HSD) deficiency is an extremely rare inborn error of metabolism (IEM) and autosomal recessive disorder of the steroidogenesis pathway. It is caused by an defect in the HSD3B2 gene which encodes for the 3 beta-hydroxysteroid dehydrogenase enzyme, which is responsible for forming cortisol from 11b,17a,21-trihydroxypregnenolone. When the enzyme is not correctly produced, cortisol levels in the cell are lowered, and as cortisol is used in the production of other steroids, it may affect their levels as well. 3-beta-HSD deficiency is characterized by low levels of cortisol produced in the adrenal glands. Symptoms include abnormal genitalia for both males and females, as well as infertility. There is also a more severe salt-wasting form of this deficiency, characterized by dehydration. Treatment for 3-beta-HSD deficiency includes steroid replacement, as well as sex hormone replacement during puberty to allow proper development. Surgery can also be used to correct any genital abnormalities that may occur. It is estimated that 3-beta-HSD deficiency affects less than 1 in 1,000,000 individuals, with around 60 cases reported.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0000718
View Pathway
|
3-beta-Hydroxysteroid Dehydrogenase Deficiency
Homo sapiens
3-beta-hydroxysteroid dehydrogenase (HSD) deficiency is an extremely rare inborn error of metabolism (IEM) and autosomal recessive disorder of the steroidogenesis pathway. It is caused by an defect in the HSD3B2 gene which encodes for the 3 beta-hydroxysteroid dehydrogenase enzyme, which is responsible for forming cortisol from 11b,17a,21-trihydroxypregnenolone. When the enzyme is not correctly produced, cortisol levels in the cell are lowered, and as cortisol is used in the production of other steroids, it may affect their levels as well. 3-beta-HSD deficiency is characterized by low levels of cortisol produced in the adrenal glands. Symptoms include abnormal genitalia for both males and females, as well as infertility. There is also a more severe salt-wasting form of this deficiency, characterized by dehydration. Treatment for 3-beta-HSD deficiency includes steroid replacement, as well as sex hormone replacement during puberty to allow proper development. Surgery can also be used to correct any genital abnormalities that may occur. It is estimated that 3-beta-HSD deficiency affects less than 1 in 1,000,000 individuals, with around 60 cases reported.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0125804
View Pathway
|
3-beta-Hydroxysteroid Dehydrogenase Deficiency
Homo sapiens
3-beta-hydroxysteroid dehydrogenase (HSD) deficiency is an extremely rare inborn error of metabolism (IEM) and autosomal recessive disorder of the steroidogenesis pathway. It is caused by an defect in the HSD3B2 gene which encodes for the 3 beta-hydroxysteroid dehydrogenase enzyme, which is responsible for forming cortisol from 11b,17a,21-trihydroxypregnenolone. When the enzyme is not correctly produced, cortisol levels in the cell are lowered, and as cortisol is used in the production of other steroids, it may affect their levels as well. 3-beta-HSD deficiency is characterized by low levels of cortisol produced in the adrenal glands. Symptoms include abnormal genitalia for both males and females, as well as infertility. There is also a more severe salt-wasting form of this deficiency, characterized by dehydration. Treatment for 3-beta-HSD deficiency includes steroid replacement, as well as sex hormone replacement during puberty to allow proper development. Surgery can also be used to correct any genital abnormalities that may occur. It is estimated that 3-beta-HSD deficiency affects less than 1 in 1,000,000 individuals, with around 60 cases reported.
|
|
- 11-Dehydrocorticosterone
- 11b,17a,21-Trihydroxypreg-neno...
- 11b,21-Dihydroxy-3,20-oxo-5b-p...
- 11b,21-Dihydroxy-5b-pregnane-3...
- 11b-Hydroxyprogesterone
- 17-Hydroxyprogesterone
- 17a,20a-Dihydroxycholesterol
- 17a,21-Dihydroxy-5b-pregnane-3...
- 17a-Hydroxypregnenolone
- 17α,21-Dihydroxypregnenolone
- 18-Hydroxycorticosterone
- 20a,22b-Dihydroxycholesterol
- 20α-Hydroxycholesterol
- 21-Deoxycortisol
- 21-Hydroxy-5b-pregnane-3,11,20...
- 21-Hydroxypregnenolone
- 22b-Hydroxycholesterol
- 3a,11b,21-Trihydroxy-20-oxo-5b...
- 3a,21-Dihydroxy-5b-pregnane-11...
- 3a-Hydroxy-5b-pregnane-20-one
- 4-Methylpentanal
- 5a-Pregnane-3,20-dione
- Aldosterone
- Cholesterol
- Cortexolone
- Corticosterone
- Cortisol
- Cortisone
- Deoxycorticosterone
- Dihydrocortisol
- Heme
- Hydrogen Ion
- NAD
- NADH
- NADP
- NADPH
- Oxygen
- Pregnenolone
- Progesterone
- Tetrahydrocorticosterone
- Tetrahydrocortisol
- Tetrahydrocortisone
- Water
- (
show all
show less
)
|
|
SMP0120661
View Pathway
|
3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency
Rattus norvegicus
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency (3-Hydroxy-3-methylglutaric acidemia; Leucine metabolism, defect in, HMG-CoA lyase deficiency) is an autosomal recessive disease caused by a mutation in the HMGCL gene which codes for hydroxymethylglutaryl-CoA lyase. A deficiency in this enzyme results in accumulation of 3-hydroxymethylglutaric acid, 3-hydroxyisovaleric acid, 3-methylcrotonylglycine and 3-methylglutaconic acid (cis and trans form), and methylglutaric acid in urine; and ammonia in blood. Symptoms include cardiomyopathy, dehydration, hypotonia, lactic acidosis, and pancreatitis. Treatment includes a low-fat, low-protein, high-carbohydrate diet.
|
|
|
|